Delivery and Specificity of CRISPR-Cas9 Genome Editing Technologies for Human Gene Therapy.

Hum Gene Ther 2015 Jul;26(7):443-51

Editas Medicine , Cambridge, Massachusetts.

Genome editing using the clustered regularly interspaced short palindromic repeats (CRISPR)-CRISPR associated 9 (Cas9) technology is revolutionizing the study of gene function and likely will give rise to an entire new class of therapeutics for a wide range of diseases. Achieving this goal requires not only characterization of the technology for efficacy and specificity but also optimization of its delivery to the target cells for each disease indication. In this review we survey the various methods by which the CRISPR-Cas9 components have been delivered to cells and highlight some of the more clinically relevant approaches. Additionally, we discuss the methods available for assessing the specificity of Cas9 editing; an important safety consideration for development of the technology.

Download full-text PDF

Source
http://dx.doi.org/10.1089/hum.2015.074DOI Listing
July 2015
57 Reads

Publication Analysis

Top Keywords

genome editing
8
therapeutics wide
4
clinically relevant
4
class therapeutics
4
wide range
4
highlight clinically
4
achieving goal
4
diseases achieving
4
range diseases
4
entire class
4
relevant approaches
4
additionally discuss
4
study gene
4
revolutionizing study
4
function will
4
approaches additionally
4
rise entire
4
will rise
4
cells highlight
4
requires characterization
4

Similar Publications